Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
61
datasets available to search
ShareScore release 0.9.0
Dataset results
61 results for “Lutetium”
Search Strategies for Lutetium and GEP-NETs
<p>The dataset includes the complete, reproducible search strategies for all literature databases searched during this project. </p>
Lutetium-177 (Lu177) Prostate-Specific Antigen (PSMA)-Directed EndoRadiotherapy
ClinicalTrials.gov study NCT03042312. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer
ClinicalTrials.gov study NCT00142415. IPD Sharing: YES. Countries: 1. Publications: 2.
Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma
ClinicalTrials.gov study NCT07316686. IPD Sharing: NO. Countries: 1. Publications: 16.
Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study
ClinicalTrials.gov study NCT02067988. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors
ClinicalTrials.gov study NCT04750954. IPD Sharing: YES. Countries: 1. Publications: 1.
In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy
ClinicalTrials.gov study NCT04343885. IPD Sharing: NO. Countries: 1. Publications: 1.
Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study
ClinicalTrials.gov study NCT02358356. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs
ClinicalTrials.gov study NCT05459844. IPD Sharing: NO. Countries: 1. Publications: 1.
Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases
ClinicalTrials.gov study NCT03590119. IPD Sharing: NO. Countries: 1. Publications: 1.
Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer
ClinicalTrials.gov study NCT04443062. IPD Sharing: UNDECIDED. Countries: 2. Publications: 4.
Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer
ClinicalTrials.gov study NCT03828838. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer
ClinicalTrials.gov study NCT02002312. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr)
ClinicalTrials.gov study NCT03658447. IPD Sharing: NO. Countries: 1. Publications: 0.
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study
ClinicalTrials.gov study NCT05496959. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open Label Registry Study of Lutetium-177 (DOTA0, TYR3) Octreotate (Lu-DOTA-TATE) Treatment in Patients with Somatostatin Receptor Positive Tumours
ClinicalTrials.gov study NCT02236910. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT05383079. IPD Sharing: NO. Countries: 1. Publications: 2.
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
ClinicalTrials.gov study NCT05939414. IPD Sharing: YES. Countries: 26. Publications: 0.
A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOp
ClinicalTrials.gov study NCT06531499. IPD Sharing: NO. Countries: 6. Publications: 0.
Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function
ClinicalTrials.gov study NCT06004661. IPD Sharing: YES. Countries: 5. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.